Akero Therapeutics Inc - Ordinary Shares

Akero Therapeutics Inc - Ordinary Shares is not very popular among insiders. Akero Therapeutics Inc - Ordinary Shares is a mediocre stock to choose.
Log in to see more information.
AKRO Fundamental Data by TradingView

News

Akero Therapeutics announces first patient dosed in Phase 3 SYNCHRONY study
Akero Therapeutics announces first patient dosed in Phase 3 SYNCHRONY study

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH
Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH

Globe Newswire Outcomes is the third study in the Phase 3 SYNCHRONY clinical trial program SOUTH SAN FRANCISCO,Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a...\n more…

AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO
AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO

PR Newswire AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO AKERO THERAPEUTICS...\n more…

Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $2,045,076.39 in Stock
Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $2,045,076.39 in Stock

Ticker Report Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) CFO William Richard White sold 75,159 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price...\n more…

Catriona Yale Sells 5,200 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock
Catriona Yale Sells 5,200 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock

Ticker Report Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) insider Catriona Yale sold 5,200 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an...\n more…

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 8,851 Shares of Stock
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 8,851 Shares of Stock

Ticker Report Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) insider Catriona Yale sold 8,851 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of...\n more…